Intellectual property rights: An overview and implications in pharmaceutical industry

Journal of Advanced Pharmaceutical Technology and Research

Volumn 2, Issue 2, 2011, Pages 88-93

  Nath Saha, Chandra ^a   Bhattacharya, Sanjib ^b  

^a Claris Lifesciences Ltd   (India)

^b Bengal School of Technology   (India)

Author keywords

Drug; Intellectual property; License; Patent; Pharmaceutical

Indexed keywords

CREATIVITY; DRUG INDUSTRY; HUMAN; HUMAN EXPERIMENT; INVENTION; INVENTOR; LICENCE; MANAGEMENT STYLE; PATENT; REVIEW;

EID: 84886412875     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/2231-4040.82952     Document Type: Review

References (24)

1. Singh R. Law relating to intellectual property (A complete comprehensive material on intellectual property covering acts, rules, conventions, treaties, agreements, case-Law and much more). Vol. 1. New Delhi: Universal Law Publishing Co. Pvt. Ltd.; 2004.
2. Anonymous. Research and development statistics. New Delhi: Department of Science and Technology (DST), Government of India; 2002.
3. Anonymous. Research and development in industry: An overview. New Delhi: Department of Scientific and Industrial Research, Government of India; 2002.
4. Bainbridge DI. Intellectual property. New York: Longman; 2002.
5. Anonymous. The Design Act. 2000 along with Design Rules 2001. New Delhi: Universal Law Publishing Co. Ltd.; 2004.
6. Anonymous. The Trademarks Act 1999 along with trade Marks Rules 2002. New Delhi: Commercial Law Publisher (India) Pvt. Ltd.; 2004.
7. Anonymous. The Copyright Act 1957 as amended up to 1999 along with Copyright Rules 1958 and International Copyright Order 1999. New Delhi: Commercial Law Publisher (India) Pvt. Ltd.; 2005.
8. Anonymous. The Geographical Indications of Goods (registration and protection) Act, 1999 along with Geographical Indications of Goods (registration and protection) Rules 2002. New Delhi: Universal Law Publishing Co. Ltd.; 2004.
9. Anonymous. The Patents Act, 1970 as amended by Patents (amendment) Act 2005. New Delhi: Commercial Law Publisher (India) Private Ltd.; 2005.
10. nd ed. London: Sweet and Maxwell; 1996.
11. Watal J. Intellectual property rights in the WTO and developing countries. London: Kluwer Law International; 2001.
12. Abbott F, Cottier T, Gurry F. The international intellectual property system: Commentary and materials. Part I. London: Kluwer Law International; 1999.
13. Beier FK, Schricker G. IIC studies: Studies in industrial property and copyright law, from GATT to TRIPS - the agreement on trade related aspects of intellectual property rights. Max Planck Institute for Foreign and International Patent. Munich: Copyright and Competition Law; 1996.
14. Anonymous. WIPO intellectual property handbook. policy, law and use. New York: WIPO Publication; 2001.
15. Gutterman AS, Anderson BJ. Intellectual property in global markets: A guide for foreign lawyers and managers. London: Kluwer Law International; 1997.
16. Bently L, Sherman B. Intellectual property law. Oxford: Oxford University Press; 2001.
17. Angell M. The Pharmaceutical Industry. To Whom Is It Accountable? N Engl J Med 2000;342:1902-4.
18. Lexchin J. Intellectual property rights and the Canadian pharmaceutical marketplace: Where do we go from here? Int J Health Serv 2005;35:237-56.
19. Mrudula BS, Durgadevi NK, Madhavi BR, Tejeswi B, Durga PV. Intellectual property rights pinpoint at IPR spotlights coveted R and D. Drug Inv Today 2009;2:197-201.
20. Glasgow LJ. Stretching the limits of intellectual property rights: Has the pharmaceutical industry gone too far? IDEA J Law Technol 2001;41:227-58.
21. Gottlieb S. Drug firms use legal loopholes to safeguard brand names. BMJ 2000;321:320.
22. Kartal M. Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products. Phytother Res 2007;21:113-9.
23. Subbaram NR. What everyone should know about patents? Hyderabad: Pharma Books Syndicate; 2003.
24. Shukla S. Patents: An Introduction. Indian Pharm 2004;3:14-7.